SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: zeta1961 who wrote (21359)9/19/2006 6:24:47 PM
From: Mike McFarland  Respond to of 52153
 
Forgot that bmy has a decent dividend, that
one looks like it bounces off of $20 or $21
over and over again; between the bounces and
capturing the dividend maybe there's something
there.

I guess I forgot all about sny (aventis),
and everything else that only pays around 2%.

What is the biotech to big pharma valuation these days?
Not Amgen, but rather the 1-20B biotechs against small
pharma?